Primary Age Related Tauopathy (Part) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Primary Age-Related Tauopathy (PART) is a neurodegenerative condition characterized by neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau protein in the absence of significant amyloid-beta plaques. It represents a biological link between normal aging and Alzheimer's disease.
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
¶ Definition and Criteria
- Neurofibrillary tangles in the medial temporal lobe
- Absence of or minimal amyloid-beta plaques
- Age of onset typically >80 years
- Cognitive impairment ranging from normal to dementia
- Mild PART: Limited to entorhinal cortex and hippocampus
- Severe PART:扩展到新皮层区域
- NFT distribution follows Braak pattern but with amyloid independence
- 3R and 4R tau isoform mixture (similar to AD)
- Pretangles and ghost tangles
- Neuritic plaques absent or rare
- Tau-positive astrocytes in some cases
- Entorhinal cortex — earliest involvement
- Hippocampus — CA1 and subiculum
- Amygdala — variable involvement
- Occipital cortex — relatively spared
- Memory impairment (amnestic syndrome)
- Progressive decline over years
- Executive function relatively preserved early
- Language and visuospatial deficits in later stages
- Slower progression typically
- Less prominent hippocampal atrophy on MRI
- Lower rates of aphasia and agnosia
- Elevated total tau
- Normal or mildly elevated p-tau
- Low Aβ42 (may be normal in pure PART)
- MRI: hippocampal atrophy
- PET: reduced glucose metabolism in medial temporal lobe
- Tau PET: positive binding in affected regions
- Prevalence increases with age
- Found in 10-30% of cognitively normal elderly
- Up to 50% of those with dementia but no amyloid
- Symptomatic treatment with cholinesterase inhibitors
- Lifestyle modifications
- Cognitive rehabilitation
- Tau-targeted immunotherapies
- Prevention strategies
- Biomarker development
The study of Primary Age Related Tauopathy (Part) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Crary et al., Primary age-related tauopathy (2014)
- Jellinger et al., PART pathology (2015)
- Duyckaerts et al., PART classification (2018)
- Hu et al., PART biomarkers (2020)